vimarsana.com
Home
Live Updates
Ablative Solutions TARGET BP I Pivotal Trial Results Demonstrate Significant Reduction in 24-Hour Ambulatory Systolic Blood Pressure Compared to Sham, Using Alcohol-Mediated Renal Denervation : comparemela.com
Ablative Solutions' TARGET BP I Pivotal Trial Results Demonstrate Significant Reduction in 24-Hour Ambulatory Systolic Blood Pressure Compared to Sham, Using Alcohol-Mediated Renal Denervation
/PRNewswire/ -- Ablative Solutions, Inc., announced that primary trial results from the TARGET BP I Pivotal Trial, evaluating alcohol-mediated renal...
Related Keywords
United States ,
Kate Rumrill ,
David Kandzari ,
Ablative Solutions ,
American College Of Cardiology ,
Scientific Congress ,
Piedmont Heart Institute ,
Prnewswire Ablative Solutions Inc ,
Ablative Solutions Inc ,
Late Breaking Clinical Trial ,
Primary Endpoint ,
Uncontrolled Hypertension ,
Treatment Arm ,
Pivotal Trial ,
Peregrine System ,
American College ,
Annual Scientific Congress ,
Peregrine System Kit ,
Piedmont Healthcare ,
Breaking Clinical Trial ,
Ambulatory Systolic Blood Pressure ,
Major Adverse Events ,
Peregrine System Infusion Catheter ,
Nc ,
Health Care Amp Hospitals ,
Clinical Trials Amp Medical Discoveries ,
comparemela.com © 2020. All Rights Reserved.